Isabelle Riviere, PhD

Secretary (2022-2025)


Dr. Riviere is director of the cell therapy and cell engineering facility at Memorial Sloan Kettering Cancer Center, where she investigates novel strategies for cell therapies and immunotherapies to increase or retarget the immune response against tumors and treat hematological disorders.

2025

Class Considerations on Immunogenicity for AAV GT Products

January 22-23, 2025 | Virtual

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.